Post Offer Free
Foshan Jiazhinuo Biotechnology Co.,Ltd
Foshan Jiazhinuo Biotechnology Co.,Ltd

China Daunorubicin Hydrochloride CAS 23541-50-6 99% Purity High Quality Material manufacturer

4th

Gold Index: 91165

You are here: home  > Pharmaceuticals  > Daunorubicin Hydrochloride CAS 23541-50-6 99% Purity High Quality Material

Daunorubicin Hydrochloride CAS 23541-50-6 99% Purity High Quality Material 

Price: 1.0 USD 
Payment Terms: T/T,WU,Money Gram;Bitcoin 
Place of Origin: Guangdong, China (Mainland) 
inquire skype
Add to My Favorites
HiSupplier Escrow
Share |

Product Detail

Means of Transport: Ocean,Land,Air
Packing: 25kg/Drum
Production Capacity: 1000kg/month
Delivery Date: 4days

CAS: 23541-50-6
MF: C27H30ClNO10
MW: 563.98
EINECS: 245-723-4
Product Categories: Intermediates & Fine Chemicals;Pharmaceuticals;Antitumour;Carboh

Product Name: Daunorubicin hydrochloride

Synonyms: WP900 HYDROCHLORIDE;daunoblastin;daunoblastina;daunomycinchlorohydrate;ndc0082-4155;ondena;rp13057hydrochloride;rubidomycinhydrochloride

CAS: 23541-50-6

MF: C27H30ClNO10

MW: 563.98

EINECS: 245-723-4

Product Categories: Intermediates & Fine Chemicals;Pharmaceuticals;Antitumour;Carbohydrates & Derivatives;Chiral Reagents;Heterocycles;API;Anti-cancer&immunity


Indications


(1) acute myeloid leukemia: either a single use of daunorubicin or in combination with other anti-tumor  , daunorubicin are suitable for the treatment of various stages of the disease. Also for the treatment of promyelocytic leukemia.

(2) acute lymphocytic leukemia: daunorubicin treatment of the disease, the remission rate is high, but because of its side effects and there are other effective treatment, so daunorubicin is only applicable to those other  have been produced Resistant cases. The combination of daunorubicin, prednisone and vincristine in the acute phase of acute lymphoblastic leukemia has proven to be very successful.

(3) other tumors: daunorubicin has been observed on neuroblastoma and rhabdomyosarcoma have a good effect.


Specifications: 20mg


Dosage and Usage


Daunorubicin oral invalid. Avoid intramuscular or intrathecal injection. Only intravenous administration. Should be the first drip of saline to ensure that the needle in the vein, and then only in this patency of intravenous infusion of daunorubicin. This technique reduces the risk of drug extravasation and ensures that the vein can be rinsed after injection. Daunorubicin must not be mixed with heparin, because these  are not compatible in the chemical nature, can produce precipitates, daunorubicin can be combined with other anti-leukemia  , but must not use the same syringe to mix these drug.


Single doses range from 0.5 mg / kg to 3 mg / kg. 0.5mg-1mg / kg dose should be separated by 1 day or more to repeat the injection; and 2mg / kg dose interval of 4 days or more to be repeated injection. Although doses of 2.5-3 mg / kg are rarely used, this dose should be repeated 7-14 days apart. Each patient needed a different number of injections. Each patient should be based on their response to  and tolerance should be based on their blood and bone marrow to adjust the dose situation, should also be considered in combination with other anti-tumor  should be adjusted dose. No matter adults or children, the total dose can not exceed 20mg / kg. Patients with liver dysfunction should be reduced, in order to avoid drug toxicity enhancement..


Ms. Karry
skype Ms. Karry
Sales Manager
Tel: 86-0757-82035343
Mobile: 86- 188 2631 2629
Contact to this supplier

Didn't find what you're looking for? Post Buying Lead or contact HiSupplier Customer Service Center  for help!

Related Search

Find more related products in following catalogs on Hisupplier.com

Other products from this supplier

Company Info

Foshan Jiazhinuo Biotechnology Co.,Ltd [China (Mainland)]


Business Type:Manufacturer, Trading Company
City: Foshan
Province/State: Guangdong
Country/Region: China (Mainland)

Karry:   skype
Karry:   qq

You May Like: